Notes / Company

Vista Pharmaceuticals Ltd.

VISTAPH BSE 524711 ISIN INE427C01021 Pharmaceuticals

Fundamentals

Market cap: ₹52.87 cr
ROE: 0.00%
Debt / equity: 0.16
52-week range: 5.71 — 12.01

The timeline — 1 note on Vista Pharmaceuticals Ltd.

May 2026

29 May 26 · 4:50 PM IST Brief

Brief · Earnings · Micro cap

Vista Pharmaceuticals posts fifth straight loss as cash dwindles

Revenue halved to ₹539.95 lakhs while the auditor flagged material uncertainty over the company's survival.

Verify on exchange BSE filings for VISTAPH NSE filings for VISTAPH